LogicBio Therapeutics (LOGC) Misses Q1 EPS by 27c

May 9, 2025 4:24 PM

LogicBio Therapeutics (NASDAQ: LOGC) reported Q1 EPS of ($0.27).

For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.